RJA
PETS icon

Raymond James & Associates’s PetMed Express PETS Stock Holding History

Raymond James & Associates’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,700
Closed -$3K – 4093
2022
Q2 		$3K Buy
+13,700
New +$306K ﹤0.01% 3996

Other funds holding PETS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James & Associates's PETS Position: Q1 2023 in Review

Raymond James & Associates sold out of PetMed Express (PETS) in Q1 2023, closing a stake of 17,647 shares — an estimated $312K sold.

Raymond James & Associates first reported a position in PETS in Q3 2013 and held it in 25 quarters. The position peaked at $1.33M in Q1 2018. 165 funds tracked by Wall St. Rank hold PETS as of Q1 2023.

  • Raymond James & Associates reported no remaining PetMed Express position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 17,647 PetMed Express shares in Q1 2023, an estimated $312K.
  • Raymond James & Associates first reported a position in PetMed Express in Q3 2013 and held it in 25 quarters.
  • Raymond James & Associates's PetMed Express position peaked at $1.33M in Q1 2018.
  • 165 funds tracked by Wall St. Rank held PetMed Express as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.